Annual SGA
$21.08 M
+$12.37 M+142.06%
December 31, 2023
Summary
- As of February 8, 2025, ACRV annual SGA is $21.08 million, with the most recent change of +$12.37 million (+142.06%) on December 31, 2023.
- During the last 3 years, ACRV annual SGA has risen by +$19.78 million (+1523.96%).
- ACRV annual SGA is now at all-time high.
Performance
ACRV SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$6.28 M
-$136.00 K-2.12%
September 30, 2024
Summary
- As of February 8, 2025, ACRV quarterly SGA is $6.28 million, with the most recent change of -$136.00 thousand (-2.12%) on September 30, 2024.
- Over the past year, ACRV quarterly SGA has increased by +$406.00 thousand (+6.92%).
- ACRV quarterly SGA is now -2.12% below its all-time high of $6.41 million, reached on June 30, 2024.
Performance
ACRV Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$575.17 M
-$76.98 M-15.45%
September 30, 2024
Summary
- As of February 8, 2025, ACRV TTM SGA is -$575.17 million, with the most recent change of -$76.98 million (-15.45%) on September 30, 2024.
- Over the past year, ACRV TTM SGA has dropped by -$594.76 million (-3036.51%).
- ACRV TTM SGA is now -2213.19% below its all-time high of -$24.86 million.
Performance
ACRV TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ACRV Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +142.1% | +6.9% | -3036.5% |
| 3 y3 years | +1524.0% | +6.9% | -3036.5% |
| 5 y5 years | +1524.0% | +6.9% | -3036.5% |
ACRV Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +754.8% | -2.1% | +448.6% | -2213.2% | at low |
| 5 y | 5-year | at high | +1524.0% | -2.1% | +1279.3% | -2213.2% | at low |
| alltime | all time | at high | +1524.0% | -2.1% | +1279.3% | -2213.2% | at low |
Acrivon Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.28 M(-2.1%) | $24.46 M(+1.7%) |
| Jun 2024 | - | $6.41 M(+3.5%) | $24.05 M(+6.2%) |
| Mar 2024 | - | $6.20 M(+11.1%) | $22.64 M(+7.4%) |
| Dec 2023 | $21.08 M(+142.1%) | $5.58 M(-5.0%) | $21.08 M(+7.6%) |
| Sep 2023 | - | $5.87 M(+17.4%) | $19.59 M(+27.6%) |
| Jun 2023 | - | $5.00 M(+7.9%) | $15.35 M(+25.8%) |
| Mar 2023 | - | $4.63 M(+13.5%) | $12.20 M(+40.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $8.71 M(+253.1%) | $4.08 M(+150.0%) | $8.71 M(+49.1%) |
| Sep 2022 | - | $1.63 M(-11.6%) | $5.84 M(+25.3%) |
| Jun 2022 | - | $1.85 M(+61.5%) | $4.66 M(+65.6%) |
| Mar 2022 | - | $1.14 M(-6.0%) | $2.82 M(+68.4%) |
| Dec 2021 | $2.47 M(+90.0%) | - | - |
| Dec 2021 | - | $1.22 M(+167.5%) | $1.67 M(+267.5%) |
| Sep 2021 | - | $455.00 K | $455.00 K |
| Dec 2020 | $1.30 M | - | - |
FAQ
- What is Acrivon Therapeutics annual SGA?
- What is the all time high annual SGA for Acrivon Therapeutics?
- What is Acrivon Therapeutics annual SGA year-on-year change?
- What is Acrivon Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Acrivon Therapeutics?
- What is Acrivon Therapeutics quarterly SGA year-on-year change?
- What is Acrivon Therapeutics TTM SGA?
- What is the all time high TTM SGA for Acrivon Therapeutics?
- What is Acrivon Therapeutics TTM SGA year-on-year change?
What is Acrivon Therapeutics annual SGA?
The current annual SGA of ACRV is $21.08 M
What is the all time high annual SGA for Acrivon Therapeutics?
Acrivon Therapeutics all-time high annual SGA is $21.08 M
What is Acrivon Therapeutics annual SGA year-on-year change?
Over the past year, ACRV annual SGA has changed by +$12.37 M (+142.06%)
What is Acrivon Therapeutics quarterly SGA?
The current quarterly SGA of ACRV is $6.28 M
What is the all time high quarterly SGA for Acrivon Therapeutics?
Acrivon Therapeutics all-time high quarterly SGA is $6.41 M
What is Acrivon Therapeutics quarterly SGA year-on-year change?
Over the past year, ACRV quarterly SGA has changed by +$406.00 K (+6.92%)
What is Acrivon Therapeutics TTM SGA?
The current TTM SGA of ACRV is -$575.17 M
What is the all time high TTM SGA for Acrivon Therapeutics?
Acrivon Therapeutics all-time high TTM SGA is -$24.86 M
What is Acrivon Therapeutics TTM SGA year-on-year change?
Over the past year, ACRV TTM SGA has changed by -$594.76 M (-3036.51%)